HomeNDC LookupRxCUI directory › RxCUI 1304111

Guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet — RxCUI 1304111

RxNorm drug concept · Semantic clinical drug
RxCUI 1304111 Semantic clinical drug · SCD ● Current RxNorm concept 10 FDA products 11 package NDCs Snapshot Jul 14, 2026

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1304111
Official nameGuaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asguaiFENesin 400 MG / phenylephrine HCl 10 MG Oral Tablet
FDA products mapped10
Package NDCs mapped11
Reported Medicaid activity (SDUD)13 prescriptions · 1 state & territory Medicaid programs · latest period Q2 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Phenylephrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes, it's the same active ingredient, but used in very different ways depending on the form. The nasal spray delivers a tiny amount directly to the nasal lining to temporarily shri...
  • I see phenylephrine in nasal sprays at the pharmacy AND as an IV drug in the hospital — is it really the same medication?
  • You should check with your doctor first. Phenylephrine constricts blood vessels, which can raise blood pressure and put extra strain on the heart — even from a nasal spray. If you...
  • Can I use the nasal spray if I have high blood pressure or heart disease?
📖 Read our full Phenylephrine guide →

🕸️ Concept Web — How Guaifenesin 400 MG / phenylephrine hydrochloride... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Guaifenesin 400 MG / phenylephrine hydrochloride 10 MG Oral Tablet RxCUI 1304111

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 4

    The active substance itself — no strength, form, or brand attached yet.

    • Guaifenesin 5032
    • Phenylephrine 8163
    • Guaifenesin / phenylephrine 214597
    • Phenylephrine hydrochloride 8164
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Guaifenesin / phenylephrine Oral Tablet 378289
    • Guaifenesin / phenylephrine hydrochloride Oral Tablet 2648658
    • Guaifenesin / phenylephrine Oral Product 1159114
    • Guaifenesin / phenylephrine Pill 1159115
    • Guaifenesin / phenylephrine hydrochloride Oral Product 2661648
    • Guaifenesin / phenylephrine hydrochloride Pill 2660754
    • Oral Tablet 317541
    • Oral Product 1151131
    • +1 more in this family
  3. Clinical & branded drugs 2

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Guaifenesin 400 MG 316015
    • Phenylephrine hydrochloride 10 MG 996705

Showing up to 8 concepts per family — 14 of 15 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Guaifenesin 400 MG SCDC · 316015
  • Phenylephrine hydrochloride 10 MG SCDC · 996705
  • Guaifenesin / phenylephrine Oral Tablet SCDF · 378289
  • Guaifenesin / phenylephrine hydrochloride Oral Tablet SCDFP · 2648658
  • Guaifenesin / phenylephrine Oral Product SCDG · 1159114
  • Guaifenesin / phenylephrine Pill SCDG · 1159115
  • Guaifenesin / phenylephrine hydrochloride Oral Product SCDGP · 2661648
  • Guaifenesin / phenylephrine hydrochloride Pill SCDGP · 2660754

📦 FDA Products & Package NDCs

10 products · 11 package NDCs
11 package NDCs map to RxCUI 1304111 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00363-0542-01 1 BOTTLE, PLASTIC in 1 CARTON (0363-0542-01) / 30 TABLET, F... Mucus Relief PE Walgreen Company 2006-04-15
00536-1309-07 1 BOTTLE, PLASTIC in 1 CARTON (0536-1309-07) / 30 TABLET in... Rugby Chest Congestion Relief PE Rugby Laboratories 2020-09-09
00536-1309-08 1 BOTTLE, PLASTIC in 1 CARTON (0536-1309-08) / 60 TABLET in... Rugby Chest Congestion Relief PE Rugby Laboratories 2020-09-09
36800-0989-50 1 BOTTLE in 1 CARTON (36800-989-50) / 50 TABLET in 1 BOTTLE Topcare Chest Congestion and Sinus Congestion Relief PE TOPCO ASSOCIATES LLC 2006-06-05
46122-0700-71 1 BOTTLE in 1 CARTON (46122-700-71) / 50 TABLET in 1 BOTTLE GNP Mucus Relief PE AmerisourceBergen Drug Corp 2022-01-13
49348-0774-09 1 BOTTLE in 1 CARTON (49348-774-09) / 50 TABLET in 1 BOTTLE Sunmark Chest Congestion Relief PE PE Strategic Sourcing Services LLC 2019-08-29
63941-0986-50 1 BOTTLE in 1 CARTON (63941-986-50) / 50 TABLET in 1 BOTTLE Always Save Mucus Relief PE Valu Merch 2023-02-06
69842-0997-60 1 BOTTLE in 1 CARTON (69842-997-60) / 60 TABLET in 1 BOTTLE CVS Health Chest Congestion Relief PE CVS Pharmacy, Inc. 2006-06-05
70000-0141-01 1 BOTTLE, PLASTIC in 1 CARTON (70000-0141-1) / 50 TABLET, F... Mucus Relief PE Sinus Congestion Cardinal Health 110, LLC. DBA Leader 2006-04-15
70677-1056-01 1 BOTTLE in 1 CARTON (70677-1056-1) / 50 TABLET in 1 BOTTLE Foster and Thrive Chest Congestion Relief PE PE Strategic Sourcing Services LLC 2024-12-18
73057-0389-04 30 TABLET, COATED in 1 BOTTLE, PLASTIC (73057-389-04) Pharbinex-PE Ulai Health LLC 2019-07-18
Observed labelers: Rugby Laboratories (2) · Strategic Sourcing Services LLC (2) · AmerisourceBergen Drug Corp (1) · Cardinal Health 110, LLC. DBA Leader (1) · CVS Pharmacy, Inc. (1) · TOPCO ASSOCIATES LLC (1) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.